Side-by-side comparison
NAD+ vs MOTS-c — Price & Profile Comparison
NAD+
Cellular CoenzymeNAD+ / longevity research
MOTS-c
Metabolic PeptideMitochondrial research
The short answer
NAD+ vs MOTS-c: which to choose
NAD+ is the cheaper option — roughly $1 vs $16 for the lowest verified listing. MOTS-c is the more widely stocked of the two (55 vendors vs 43). They target different goals — NAD+ is a cellular coenzyme compound while MOTS-c is a metabolic peptide one — so they're often complementary rather than direct substitutes.
Research products are not for human use. Looking for clinician-supervised care instead? Compare licensed US telehealth programs that may offer provider-guided peptide protocols when clinically appropriate.
Compare supervised options →Price Comparison — 2026
NAD+
MOTS-c
Vendors Carrying Both
43 vendors stock both NAD+ and MOTS-c — convenient if you want to bundle an order.
Safety Notes
NAD+
FDA: Not FDA-approved (injectable)
IV widely used in clinics; flushing/nausea common but transient; endogenous molecule; no serious AEs reported
MOTS-c
FDA: Not FDA-approved
Endogenous mitochondrial peptide; human study showed safety in metabolic syndrome; promising early data
